Aquí puede consultar el articulo con los resultados principales del estudio:
Long-term secondary prevention of cardiovascular disease with a Mediterranean diet and a low-fat diet (CORDIOPREV): a randomised controlled trial https://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(22)00122-2.pdf#back-bib7
Puede consultar las publicaciones científicas relacionadas con el estudio CORDIOPREV
cordioprev cordioprev: Latest results from PubMed
- High density lipoprotein subfractions and extent of coronary atherosclerotic lesions: From the cordioprev studypor Silvia de la Cruz-Ares el junio 14, 2022 a las 10:00 am
CONCLUSION: In CHD patients mostly on statin treatment, angiography severity is inversely related to small and medium HDL subclasses concentration measured by NMR. These particles are also independent predictors of the presence of MVD, and its use increased the prediction of this entity over traditional risk factors.
- Long-term secondary prevention of cardiovascular disease with a Mediterranean diet and a low-fat diet (CORDIOPREV): a randomised controlled trialpor Javier Delgado-Lista el mayo 7, 2022 a las 10:00 am
BACKGROUND: Mediterranean and low-fat diets are effective in the primary prevention of cardiovascular disease. We did a long-term randomised trial to compare the effects of these two diets in secondary prevention of cardiovascular disease.
- Long-term effect of a dietary intervention with two-healthy dietary approaches on food intake and nutrient density in coronary patients: results from the CORDIOPREV trialpor Naomi Cano-Ibáñez el marzo 29, 2022 a las 10:00 am
CONCLUSIONS: A comprehensive dietary intervention improved quality of diet, reducing total energy intake and increasing the intake of healthy food groups and overall ND after 1 year and maintaining this trend after 7 years of follow-up. Our results reinforce the idea of the participation in trials, enhance nutrition literacy and produces better nutritional outcomes in adult patients with established CVD.
- Long-term consumption of a mediterranean diet or a low-fat diet on kidney function in coronary heart disease patients: The CORDIOPREV randomized controlled trialpor Alicia Podadera-Herreros el enero 14, 2022 a las 11:00 am
CONCLUSIONS: The long-term consumption of a Mediterranean diet rich in EVOO, when compared to a low-fat diet, may preserve kidney function, as shown by a reduced decline in eGFR in CHD patients with T2DM. Patients with mildly-impaired eGFR may benefit more from the beneficial effect of the consumption of the Mediterranean diet in preserving kidney function. These findings reinforce the clinical benefits of the Mediterranean diet in the context of secondary cardiovascular disease prevention.
- An altered microbiota pattern precedes Type 2 diabetes mellitus development: From the CORDIOPREV studypor Cristina Vals-Delgado el enero 13, 2022 a las 11:00 am
CONCLUSION: These results suggest that a microbiota profile is associated to the T2DM development. An integrate predictive model of microbiome and clinical data that can improve the prediction of T2DM is also proposed, if is validated in independent populations to prevent this disease.